From margin to mainstream: The evolution of harm reduction responses to problem drug use in Europe

Drugs: Education, Prevention and Policy

Volumn 15, Issue 6, 2008, Pages 503-517

  Hedrich, Dagmar ^a   Pirona, Alessandro ^a   Wiessing, Lucas ^a  

^a EUROPEAN MONITORING CENTRE FOR DRUGS AND DRUG ADDICTION   (Portugal)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 55849089617     PISSN: 09687637     EISSN: 14653370     Source Type: Journal    
DOI: 10.1080/09687630802227673     Document Type: Article

References (27)

1. Bargagli, A. M., Hickman, M., Davoli, M., Perucci, C. A., Schifano, P., Buster, M., et al. (2005). Drug-related mortality and its impact on adult mortality in eight European countries. European Journal of Public Health, 16(2), 198-202.
2. Bargagli, A. M., Sperati, A., Davoli, M., Forastiere, F., & Perucci, C. A. (2001). Mortality among problem drug users in Rome: An 18-year follow-up study, 1980-97. Addiction, 96, 1455-1463.
3. Bergeron, H., & Kopp, P. (2002). Policy paradigms, ideas, and interests: The case of the French Public Health Policy toward drug abuse. The ANNALS of the American Academy of Political and Social Science, 582(1), 37-48.
4. Best, D., & Campbell, A. (2007). The NTA's 2006 National Prescribing Audit. An assessment of prescribing practices for opioid substitution treatment in England, 2004-05, London, UK: The National Treatment Agency for Substance Misuse (NTA). (Available at: http://www.nta.nhs.uk/publications/documents/ nta_npal_prescribing_audit.pdf. Date last accessed 22/2/08).
5. Commission of the European Communities (COM). (2004). Communication from the Commission to the Council and the European Parliament on the results of the final evaluation of the EU drugs strategy and action plan on drugs (2000-2004). (Available at: http://eur-lex.europa.eu/LexUriServ/site/en/com/ 2004/com2004_0707en01.pdf).
6. Commission of the European Communities (COM). (2007). Report from the Commission to the European Parliament and the Council on the implementation of the Council Recommendation of 18 June 2003 on the prevention and reduction of health-related harm associated with drug dependence. (Available at: http://eur-lex.europa.eu/LexUriServ/site/en/com/2007/com2007_0199en01.pdf - date last accessed 22 February 2008).
7. De la Fuente,-L., Brugal, M. T., Domingo-Salvany, A., Bravo, M. J., Neira-León, M., & Barrio, G. (2006). Más de treinta años de drogas ilegales en España: una amarga historia con algunos consejos para el futuro [More than thirty years of illicit drugs in Spain: A bitter story with some messages for the future]. Revista Española de Salud P-blica, 80(5), 505-520.
8. Diamandouros, N. (2005). The European Ombudsman and EU drugs policy. 'Drug addiction, treatment and prevention in a United Europe: Diversity and equality'. Speech at the 10th European Conference on Rehabilitation and Drug Policy, Hersonissos, Crete, May 2005. (Available at: http://ombudsman.europa.eu/speeches/en/2005-05-14.htm).
9. Dole, V. P., & Nyswander, M. E. (1965). Medical treatment for diacetylmorphine (heroin) addiction. Journal of the American Medical Association, 193, 646-650.
10. EMCDDA. (2004). A European perspective on responding to blood borne infections among injecting drug users. A Short Briefing Paper prepared by the European Monitoring Centre for Drugs and Drug Addiction (EMCDDA) at the request of the Horizontal Drugs Group of the Council of the European Union. (Available at: www.emcdda.europa.eu/html.cfm/index5777EN.html - date last accessed 22 February 2008).
11. EMCDDA. (2005). Annual report 2005: The state of the drugs problem in Europe. Lisbon, Portugal: European Monitoring Centre for Drugs and Drug Addiction.
12. EMCDDA. (2006). Annual report 2006: The state of the drugs problem in Europe. Lisbon, Portugal: European Monitoring Centre for Drugs and Drug Addiction.
13. Emmanuelli, J., & Desenclos, J. C. (2005). Harm reduction interventions, behaviours and associated health outcomes in France, 1996-2003. Addiction, 100(11), 1690-1700.
14. Estonian National Focal Point/National Institute for Health Development. (2006). National report on the drugs situation in Estonia. Tallinn, Estonia: National Institute for Health Development publications.
15. Euro-HIV. (1996, June). The HIV epidemic associated with injecting drug use in Europe, 1985-1995, HIV/AIDS Surveillance in Europe, 50. (Available at: http://www.eurohiv.org/reports/report_50/hiv_epidemic.pdf. - date last accessed 22 February 2008).
16. Farrell, F., Verster, A., Davoli, M., Nilson, M., & Merino, P. P. (2000). Reviewing current practice in drug-substitution treatment in the European Union. EMCDDA Insights Series, 3. Lisbon, Portugal: EMCDDA publications.
17. Frischer, M., Goldberg, D., Rahman, M., & Berney, L. (1997). Mortality and survival among a cohort of drug injectors in Glasgow, 1982-1994. Addiction, 92(4), 419-427.
18. Hartnoll, R. (2003). Drug epidemiology in the European institutions: Historical background and key indicators. Bulletin on Narcotics, 55(1-2), 53-71.
19. Hartnoll, R., Avico, U., Ingold, F. R., Lange, K., Lenke, L., O'Hare, A., et al. (1989). A multi-city study of drug misuse in Europe. Bulletin on Narcotics, 41(1-2), 3-27.
20. Kouvonen, P., Skretting, A., & Rosenqvist, P. (2006). Drugs in the Nordic and Baltic Countries. Common concerns, different realities. NAD, 48. Helsinki: Nordic Council for Alcohol and Drug Research publications.
21. Kringsholm, B., Kaa, E., Steentoft, A., Worm, K., & Simonsen, K. W. (1994). Deaths among drug addicts in Denmark in 1987-1991. Forensic Science International, 10;67(3), 185-195.
22. Lepère, B., Gourarier, L., Sanchez, M., Adda, C., Peyret, E., Nordmann, F., et al. (2001). Reduction in the number of lethal heroin overdoses in France since 1994. Focus on substitution treatments. Annales de Médecine Interne, 152(3), 5-12.
23. Michels, I. I., Stóver, H., & Gerlach, R. (2007). Substitution treatment for opiate addicts in Germany. Harm Reduction Journal, 4(5) (Available at: http://www.harmreductionjournal.com/content/pdf/1477-7517-4-5. pdf).
24. Observatoire français des drogues et des toxicomanies (OFDT). (2004). Les traitements de substitution en France: résultats récents 2004. Tendances, 37 (Available at: http://www.ofdt.fr/ ofdtdev/live/publi/tend/tend37_fr.html).
25. Strang, J., & Gossop, M. (2005). Heroin addiction and the British system. TV. 1: Origins and evolution. New York: Routledge.
26. Topp, L., Day, C., & Degenhardt, L. (2003). Changes in patterns of drug injection concurrent with a sustained reduction in the availability of heroin in Australia. Drug and Alcohol Dependence, 70(3), 275-286.
27. World Health Organization. (2004). The practices and context of pharmacotherapy of opioid dependence in Central and Eastern Europe. Department of Mental Health and Substance Abuse, document WHO/MSD/MSB/04.1. Geneva, Switzerland: World Health Organization. (Available at: http://www.who.int/substance_abuse/publications/en/opioid_dependence_ceec.pdf. - date last accessed 22 February 2008).